Skip to main content
. 2020 Aug 21;72(10):e506–e514. doi: 10.1093/cid/ciaa1228

Table 2.

Estimated Bed-day Costs

Opportunity cost, mean (SD) Accounting cost, mean (SD)
Per infection R S R-Sa Per infection R S R-Sa
Bloodstream infections
S. aureus 909.1 (97.6) 1347.7 (144.4) 844.6 (91.1) 503.2 (172.9) 9877.8 (999.8) 14 617.7 (1481.5) 9194.8 (926.4) 5422.9 (1744.2)
E. faecium 573.9 (68.4) 318.0 (36) 760.3 (83.1) −442.3 (90.8) 6236.9 (722.8) 3448.6 (366.1) 8253.6 (838.7) −4805.0 (916.7)
E. coli 399.7 (45.7) 403.6 (43.8) 401.0 (44.6) 2.7 (62.7) 4341 (465.4) 4402.5 (449.9) 4350.7 (453.2) 51.8 (634.2)
K. pneumoniae 526.3 (57.4) 1250.1 (137.3) 496.5 (53.9) 753.5 (147.9) 5730.3 (589.7) 13 597.6 (1415.1) 5391.6 (554.3) 8206.1 (1516.8)
P. aeruginosa 571.9 (62.3) 898.5 (106.4) 555.9 (60.7) 342.6 (123.1) 6224.3 (632.1) 9774.1 (1104.3) 6055.2 (617.7) 3718.9 (1262.2)
Urinary infections
S. aureus 257.4 (30.5) 415.8 (52.3) 235.3 (27.8) 180.5 (59.6) 2793.3 (309.1) 4508.6 (539.1) 2555.5 (285.4) 1953.1 (608.5)
E. faecium 184.1 (23.3) 244.9 (29.7) 152.3 (20.3) 92.6 (36) 2001.6 (242.7) 2662.3 (307.8) 1652.3 (210.8) 1010.0 (370.6)
E. coli 87.5 (15.1) 173.8 (22.5) 90.6 (15.2) 83.2 (27.3) 949.4 (161) 1891.9 (229.4) 986.4 (162.4) 905.5 (283.5)
K. pneumoniae 54.9 (13.1) 418.6 (54.3) 36.7 (12.5) 381.8 (55.7) 597.5 (140.7) 4560.4 (571.4) 400.0 (137.2) 4160.3 (588.9)
P. aeruginosa 145.8 (20) 348.7 (39.6) 139.1 (19.1) 209.5 (44) 1584.2 (209.8) 3784.8 (411.6) 1511.5 (196.5) 2273.3 (457.8)
Respiratory infections
P. aeruginosa 486.4 (53.5) 412.4 (46.1) 498.8 (54.6) −86.4 (71.6) 5294.8 (545.5) 4475.8 (471.2) 5421.9 (561.3) −946 (734.2)

Data are represented as opportunity and accounting costs associated with health care–associated infections in Queensland (2012–2016).

Abbreviations: E. coli, Escherichia coli; E. faecium, Enterococcus faecium; K. pneumoniae, Klebsiella pneumoniae; P. aeruginosa, Pseudomonas aeruginosa; R, resistant; S, sensitive; S. aureus, Staphylococcus aureus; SD, standard deviation.

aCost of resistance calculated as the difference in cost between a resistant and sensitive infection.